Cue Biopharma, Inc. (CUE) scores 59 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is $0.68, representing a 167% margin of safety. Quantitative score: 74/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.